Companies Kick Off Veganuary With New Food and Tech Offerings for Growing Market

FN Media Group Presents Market Commentary   New York, NY – January 20, 2022 – For the first time in history, there’s now a monthly health cause wrapped around veganism called Veganuary, which started in January 2021. A record number of people, including meat-eaters, participated in this challenge to experiment with animal-free diets against […]

Growing Acceptance Of Digital Health Services is a Huge Boon for Healthcare Cloud Computing Market

Palm Beach, FL – January 20, 2022 – News Commentary – Cloud computing increases real-time data collection and improves accessibility to the data. It has outpaced the conventional paper healthcare system by providing more speed and efficiency in data handling. For instance, cloud computing technology is widely used in remote patient monitoring. Rising demand […]

Silver Could Outperform Gold in 2022

FN Media Group Presents Market Commentary   New York, NY – January 20, 2022 – After a year of underperformance, investors may turn to silver again this year. Silver’s price action has suffered in 2021 in part due to supply bottlenecks and significantly rising energy costs. Industrial silver will contribute to the precious metal’s […]

Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer

Palm Beach, FL – January 20, 2022 – News Commentary – Despite significant progress in the treatment of gastric cancer, it is still among the leading causes of deaths due to cancer, across the world. The high mortality rates are primarily caused by the late diagnosis of the disease, with patients often missing the opportunity […]

Mapping the Future of Autonomous Vehicles Goes Right Through a SPAC

NetworkNewsWire Editorial Coverage   New York, NY – January 20, 2022 – Mainstream fully autonomous vehicles are not an if, they are a when. The bigger question is what it is going to take from a technical end to get self-driving cars and trucks safely maneuvering along every side street and highway. As one can […]

Oncolytics Biotech® Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium

Successfully enrolled first-line metastatic pancreatic and third-line metastatic colorectal safety run-ins    Company moving to full enrollment pending independent safety review    Multi-center trial being conducted in collaboration with Roche and AIO builds on prior promising data from pancreatic and colorectal cancer trials   SAN DIEGO, CA and CALGARY, AB –  January 20, 2022 — […]